Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis
Abstract Sarcopenia prevalence and its clinical impact are reportedly variable in chronic obstructive pulmonary disease (COPD) due partly to definition criteria. This review aimed to identify the criteria used to diagnose sarcopenia and the prevalence and impact of sarcopenia on health outcomes in p...
Main Authors: | Walter Sepúlveda‐Loyola, Christian Osadnik, Steven Phu, Andrea A. Morita, Gustavo Duque, Vanessa S. Probst |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12600 |
Similar Items
-
Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)
by: Hong KS, et al.
Published: (2020-05-01) -
Sarcopenia correlates with systemic inflammation in COPD
by: Byun MK, et al.
Published: (2017-02-01) -
Prevalence of Sarcopenia Among the Elderly in Korea: A Meta-Analysis
by: Yoo Jin Choo, et al.
Published: (2021-03-01) -
Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia
by: R.W. Dal Negro, et al.
Published: (2016-01-01) -
The prevalence of sarcopenia in patients with rheumatological pathology
by: Iuliia V. Lavrishcheva, et al.
Published: (2021-05-01)